Qualified Participants Must:
• Be between the ages of 18 and 65
• Have been diagnosed with Type 1 Diabetes at least 6 months prior to screening
• be on a stable once daily dose of Lantus or Toujeoand multiple daily bolus injections of Novolog for at least 3 months prior to screening
• have HbA1c levels between 6.5 and 10%
• Be able and willing to self-monitor blood glucose, including up to 7 times per day on selected days
Qualified Participants May Receive:
All trial-related medications; glucose meter and supplies, monetary compensation for time and travel